A Trial of Two Electrosurgical Conizations: Histopathological Analysis of

Status Completed

Clinical Trial Summary

The purpose of this trial is to evaluate if Straight Wire Excision of the Transformation Zone (SWETZ) is superior to (Large Loop Excision of the Transformation Zone) LLETZ cone in reducing the incomplete excision of disease.

Clinical Trial Description

Cone biopsy is a surgical procedure which objectives the excision of endocervical pre-invasive disease located at transformation zone or glandular epithelium. Although cone biopsy is considered adequate for the treatment of endocervical dysplastic epithelium , using electrosurgery as opposed to the cold knife technique of cone biopsy has been criticized because of the perceived potential for incomplete excision of disease, thermal damage and surgical specimen fragmentation, which might increase the risk of missing early invasive cancer. Also, incomplete excision margin of disease exposes women to an increased risk of residual post-treatment disease.

The standard procedure, Large Loop Excision of the Transformation Zone (LLETZ-cone), is performed with a large loop electrode of 20-25 mm depth.

The experimental intervention is Straight Wire Excision of the Transformation Zone (SWETZ), a method of excision using a 1cm straight disposal of 0.20 wire to remove the endocervical transformation zone or glandular disease.

Both procedures were previously studied in another clinical trial(NCT00995020), but the histological analysis were inconclusive for many outcomes. SWETZ were superior to LLETZ cone to acquire complete excision of disease, with no statistical significance, probably due to the small sample size.

This study objectives a better histological analyses of the surgical specimens related to incomplete excision, thermal damage and fragmentation. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01929993
Study type	Interventional
Source	Oswaldo Cruz Foundation
Contact
Status	Completed
Phase	Phase 3
Start date	January 2008
Completion date	February 2012

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04537156` - Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)	Phase 3
Completed	`NCT02907333` - Testing Use of Condoms on Regression of Cervical Intraepithelial Neoplasia	N/A
Recruiting	`NCT02576262` - HPV Integration Testing for Human Papillomavirus-Positive Women	N/A
Completed	`NCT01029990` - Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening Program	Phase 0
Recruiting	`NCT05078528` - Low-cost Imaging Technology for Global Prevention of Cervical Cancer	N/A
Recruiting	`NCT05502367` - A Study of ABI-2280 Vaginal Tablet in Participants With Cervical Intraepithelial Neoplasia	Phase 1/Phase 2
Completed	`NCT02494310` - HRME: Screening for Cervical Cancer and Its Precursors in Low‐Resource Settings	N/A
Active, not recruiting	`NCT03429582` - Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device	N/A
Active, not recruiting	`NCT02140021` - Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer	N/A
Not yet recruiting	`NCT05510830` - Diagnostic Cervical Conization for Persistent Infection or Integration of HPV	N/A
Completed	`NCT02237326` - Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women	N/A
Completed	`NCT00316706` - Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine	Phase 3
Withdrawn	`NCT03143491` - Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)	Phase 2
Completed	`NCT03293628` - Comparing Two Techniques of Haemostasis After Cervical Conization	Phase 2
Recruiting	`NCT05266898` - Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV	Phase 4
Completed	`NCT02481414` - A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions	Phase 2
Completed	`NCT02247999` - Improving Cervical Cancer Screening Among HIV-Infected Women in India
Recruiting	`NCT04646954` - DNA Methylation Testing for the Screening of Uterine Cervical Lesion	Phase 3
Recruiting	`NCT04650711` - Immunohistochemical Staining of p16 for the Screening of Cervical Cancer	Phase 2
Completed	`NCT01544478` - V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms